Isolation of the active form of RAC-protein kinase (PKB/Akt) from transfected COS-7 cells treated with heat shock stress and effects of phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 4,5-bisphosphate on its enzyme activity  by Matsuzaki, Hidenori et al.
FEBS 17726 FEBS Letters 396 (1996) 305-308 
Isolation of the active form of RAC-protein kinase (PKB/Akt) from 
transfected COS-7 cells treated with heat shock stress and effects of 
phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 
4,5-bisphosphate on its enzyme activity 
Hidenori Matsuzaki a, Hiroaki Konishi b, Motonari Tanaka a, Yoshitaka Ono a, 
Tadaomi Takenawa c, Yutaka Watanabe d, Shoichiro Ozaki d, Shun'ichi Kuroda b, 
Ushio Kikkawa b,* 
~Department of Biology, Faculty of Science, Kobe University, Kobe 657, Japan 
bBiosignal Research Center, Kobe University, Kobe 657, Japan 
"Department of Biochemistry, Institute of Medical Science, University of Tokyo, Tokyo 113, Japan 
aDepartment ofApplied Chemistry, Faculty of Engineering, Ehime University, Matsuyama 790, Japan 
Received 9 September 1996; revised version received 26 September 1996 
Abstract RAC-protein kinase (PKBIAkt) has been shown to be 
activated by growth factor stimulation as a downstream target of 
phosphatidylinositol 3-kinase and also by heat shock through a 
pathway independent of phosphatidylinositol 3-kinase. RAC- 
protein kinase was purified by antibody affinity chromatography 
from COS-7 cells transfected with the epitope-tagged expression 
plasmid. The protein kinase activity of RAC-protein kinase 
purified from heat-treated cells was 9-fold higher than the 
enzyme isolated from untreated control cells. Phosphatidylino- 
sitol 3,4,5-trisphosphate did not enhance the activity of RAC- 
protein kinase purified from either heat-treated cells or control 
cells, whereas phosphatidylinositol 4,5-bisphosphate suppressed 
the enzyme isolated from heat-treated cells. These results 
indicate that RAC-protein kinase may interact with phospho- 
inositides, however, it could not be activated by simple association 
with the product of phosphatidylinositol 3-kinase reaction. 
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1. Introduction 
protein kinase having a PH domain and a catalytic domain 
closely related to both cAMP-dependent protein kinase and 
PKC in its amino- and carboxyl-terminal regions, respectively 
[8-14], has been indicated to be a downstream target of PI 
3-kinase [15-19]. Namely, it has been shown that RAC-PK is 
activated by several growth factors, and that growth factor- 
induced activation of RAC-PK  is blocked by PI 3-kinase in- 
hibitors and by the expression of a dominant-negative mutant 
of PI 3-kinase, and platelet derived growth factor-receptor 
mutants which fail to activate PI 3-kinase are incapable of 
activation of RAC-PK.  PtdIns(3)P, one of the products of 
the PI 3-kinase reaction, has been shown to activate directly 
RAC-PK  in vitro and has been suggested to bind to the PH 
domain of RAC-PK  [15], as PtdIns(4,5)P2 recognizes the hy- 
drophobic pocket of the PH domain [20]. Very recently, RAC- 
PK has been revealed to be activated by cellular stress such as 
heat shock and hyperosmolarity in a manner independent of 
PI 3-kinase [21]. Thus, RAC-PK  seems to be regulated by 
distinct mechanisms in signal transducing pathways. In this 
study, the active and inactive forms of RAC-PK were purified 
from transfected COS-7 cells to study the mechanism of acti- 
vation of this enzyme. 
Stimulation of the intrinsic protein tyrosine kinase activity 
of growth factor receptors by ligand-binding initiates several 
signaling pathways, and one of these signaling pathways in- 
volves PI 3-kinase, which phosphorylates the hydroxyl group 
at position 3 of the inositol ring of phosphoinositides, gener- 
ating Ptdlns(3)P, Ptdlns(3,4)P2 and Ptdlns(3,4,5)P3 [1,2]. 
These phospholipids have been considered to be second mes- 
sengers ince any known phospholipase type C can not cleave 
the inositol group with 3-phosphate. In fact, Ptdlns(3,4)P2 
and Ptdlns(3,4,5)P3 have been reported to activate some 
PKC subspecies in vitro [3-7]. Recently, RAC-protein kinase 
(RAC-PK, also named as PKB or Akt), a serine/threonine 
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2. Materials and methods 
2.1. Cells and transfection 
COS-7 cells were maintained in Dulbecco's modified Eagle's me- 
dium supplemented with 10% fetal bovine serum at 37°C in a 5% CO2 
incubator. The expression plasmid of FLAG-epitope tagged RAC- 
PKc~ which contains the cDNA insert of rat RAC-PKc~ in the 
pECE vector was transfected to COS-7 cells by electroporation using 
GENE PULSAR (Bio-Rad). The expression plasmid of dominant 
negative RAC-PKc~ (KI79M) was constructed as described [21]. A 
CHO cell line stably overproducing FLAG epitope tagged RAC- 
PK0t was constructed by using a pRc/CMV vector system (Invitro- 
gen), and maintained in Dulbecco's modified Eagle's medium contain- 
ing 10% fetal bovine serum and proline (35 lag/ml) at 37°C in a 5% 
CO2 incubator. 
2.2. Immunoprecipitation 
The following procedures were carried out at 0-4°C. Cells were 
washed with phosphate-buffered saline, and lysed in 20 mM Tris- 
HCI at pH 7.5 containing 1 mM EDTA, 1 mM EGTA, 10 mM 
2-mercaptoethanol, 1%Triton X-100, 150 mM NaC1, 10 mM NaF, 
1 mM Na3VO4 and 50 ~tg/ml phenylmethylsulfonyl fluoride (lysis 
buffer). After centrifugation for 10 min at 18 000 × g, the supernatant 
(500-600 ~g of protein) was incubated for 1 h with an anti-FLAG 
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monoclonal antibody (1 gg of protein, Kodak Scientific Imaging Sys- 
tems), and then protein A-Sepharose beads (Pharmacia) were added 
to the mixture and incubated for 30 min. The immunoprecipitates 
were collected by centrifugation and washed four times with 20 mM 
Tris-HCl at pH 7.5 containing 150 mM NaCI and 1% Triton X-100. 
2.3. Purification of  RAC-PKeL 
COS-7 cells were transfected with the expression plasmid of FLAG- 
epitope tagged RAC-PKc~ and cultured for 48 h with 10% fetal bovine 
serum at 37°C. FLAG-epitope tagged RAC-PKc~ was purified either 
from cells treated at 45°C for 20 min or from cells without reatment. 
The purification procedures were carried out at 0M°C. The extract 
from COS-7 cells (1 × 107 cells) was applied to a FLAG M2 affinity 
gel column (0.8×2 cm, Kodak Scientific Imaging Systems) equili- 
brated with lysis buffer without Triton X-100. After extensive wash- 
ing, FLAG-RAC-PK was eluted with 1 ml of 0.1 M glycine-HCI at 
pH 3.0. The eluate was neutralized immediately by adding 20 131 of 
1 M Tris-HCl at pH 8.0, and used for the protein kinase assay. About 
1 lag of purified FLAG RAC-PKc~ per 10 cm dish of confluent COS-7 
cells was obtained by these purification methods. The enzyme ob- 
tained was stable for at least 1 week when stored at 04°C. 
2.4. Protein kinase assay 
The core histone fraction (a mixture of H2A, H2B, H3, and H4 
histones) prepared from calf thymus was employed for the routine 
assay for RAC-PK. The reaction mixture (25 gl) containing 20 mM 
Tris-HCl at pH 7.5, 10 mM MgCI2, 20 mM ATP, 15-50 kBq of 
[y-3ZP]ATP, 200 gg/ml core histone and the enzyme fraction was in- 
cubated for 30 min at 30°C. After boiling in SDS sample buffer, 
phosphorylated proteins were separated by SDS-PAGE, and the 
radioactivity of protein bands was determined using a Bio-imaging 
Analyzer BAS2000 (Fuji). When immunoprecipitated enzyme was em- 
ployed, the immunoprecipitates were washed before the protein kinase 
assay with 20 mM Tris-HCl at pH 7.5 containing 1mM EDTA, 1 mM 
EGTA, 10 mM 2-mercaptoethanol, 150 mM NaC1 and 50 gg/ml 
phenylmethylsulfonyl fluoride at 0~,°C to remove Triton X-100, 
NaF and Na3VO4. Autophosphorylation f RAC-PKc~ was moni- 
tored by the phosphorylation reaction without exogenous phosphate 
acceptor proteins. Where indicated, PtdIns(4,5)P2 (bovine brain, 
Boehringer Mannheim) and PtdIns(3,4,5)P3 (fatty acid moieties are 
palmitate, C16:0) [22] dissolved in water by vigorous mixing were 
added to the reaction mixture. 
2.5. Immunoblot analysis" 
After boiling in SDS sample buffer, and proteins were separated by 
SDS-PAGE and transferred onto an Immobilon P membrane (Milli- 
pore), lmmunoblot analysis was carried out using the polyclonal anti- 
body against RAC-PKc~ as the first antibody and the alkaline phos- 
phatase-conjugated anti-rabbit second antibody (Promega) as 
described [13]. 
3. Results and discussion 
The effects of growth factor signal and heat shock on RAC- 
PK  were studied in serum-starved cells such as COS-7 cells 
transiently expressing the FLAG-epitope tagged RAC-PKc~ 
and CHO cells stably overproducing the enzyme (Fig. 1). In 
the previous study using CHO cells expressing the wild type of 
RAC-PKcq RAC-PKc~ was activated by heat shock but not 
by serum [21]. After prolonged serum starvation, treatment 
with fetal bovine serum induced activation of RAC-PK  in 
CHO cells overproducing the enzyme (Fig. 1B). It is not clear 
why CHO cells expressing the wild-type and epitope-tagged 
enzymes show different responses, however, serum-induced 
activation of RAC-PK  might depend on the amounts of en- 
zyme expressed in CHO cells, since the expression of the epi- 
tope-tagged RAC-PKc~ is lower than that of the wild-type 
enzyme. Thus, the effects of serum and heat treatment were 
compared employing COS-7 cells and CHO cells. Either 
serum or heat shock activated RAC-PK,  and the serum stim- 
ulation and heat shock were not additive for activation of 
RAC-PK  (Fig. 1A,B). A l though serum and heat treatment 
activate RAC-PK  in different manners,  it is difficult to distin- 
guish the effects of serum stimulation and heat shock since 
heat shock induces activation of RAC-PK  in cells cultured in 
the presence of serum [21]. Furthermore,  activation of RAC- 
PK has been demonstrated using immunoprecipitated en- 
zymes that might contain other materials that could regulate 
the enzyme activity [15-20]. Thus, RAC-PK  was purified to 
study the molecular mechanism of activation of RAC-PK.  
The epitope-tagged RAC-PKc~ was isolated from COS-7 cells 
transfected with the expression plasmid and cultured in the 
presence of fetal bovine serum by using affinity chromatogra- 
phy on the resin coupled with a monoclonal  ant ibody to the 
FLAG epitope (Fig. 2). RAC-PK  was purified to apparent 
homogeneity from the heat-treated cells and control cells 
(Fig. 2A). The enzyme purified from heat-treated cells without 
any obvious associating proteins showed a much higher en- 
zyme activity than that purified from untreated control cells 
(Fig. 2B). The kinase-negative RAC-PK  (K179M) was also 
purified using the same procedures, and the enzyme prepara- 
tions isolated from both the heat-treated and control cells did 
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Fig. I. Activation of RAC-PKo~ in COS-7 and CHO cells. Cells were treated as indicated and RAC-PKc~ was immunoprecipitated by the anti- 
FLAG antibody. Protein kinase activity measured by using core histone as substrate is shown in the upper panel. The amounts of RAC-PKc~ 
in the immunoprecipitates are shown by immunoblot analysis in the lower panels. Cells treated at 45°C for 20 min, with 10% fetal bovine 
serum for 20 min, and without treatment are indicated as (hs), (+), and ( ), respectively, above the upper panel. The positions of RAC-PKa 
and phosphorylated histone are indicated by arrows. (A) COS-7 cells. Cells were transfected with the expression plasmid of FLAG-epitoped 
tagged RAC-PKe~, cultured for 24 h, serum-starved for 12 h, and treated as indicated. (B) CHO cells. Cells overproducing FLAG-epitope 
tagged RAC-PKc~ were serum-starved for 24 h, and treated as indicated. 
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Fig. 2. RAC-PKc~ purified from transfected COS-7 cells. FLAG-epitope tagged RAC-PKc~ was purified from cells without treatment or from 
cells treated at 45°C for 20 min. (A) Purification of RAC-PKc~. Purified RAC-PKot (0.2 p.g) was applied on SDS-PAGE and stained with Coo- 
massie brilliant blue (left panel) and immunoblotted with the anti -RAC-PK antibody (right panel). Lanes 1,2: RAC-PKc~ purified from un- 
treated and heat-treated COS-7 cells, respectively. The positions of size markers are indicated in kDa, and the position of RAC-PKc~ is indi- 
cated by an arrow. (B) Protein kinase activity of RAC-PKcc. Purified RAC-PKc~ (0.1 gg) was employed to measure protein kinase activity by 
autophosphorylation (lanes 1,2) and by using core histone as substrate (lanes 3,4). Lanes 1,3: RAC-PKc~ purified from untreated cells; lanes 
2,4, RAC-PK~ purified from heat-treated cells. The positions of RAC-PKc~ and phosphorylated protein are indicated by arrows. 
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Fig. 3. Effects of Ptdlns(4,5)P2 and Ptdlns(3,4,5)P3 on purified RAC-PK~. RAC-PK~ purified from COS-7 cells without treatment and from 
heat-treated cells was assayed by using core histone as substrate in the presence of various concentrations of PtdIns(4,5)P2 and PtdIns(3,4,5)P3. 
(A) Autoradiography of the phosphorylation of core histone. RAC-PKc~ was assayed in the presence of PtdIns(4,5)P2 (upper half) and 
Ptd|ns(3,4,5)P3 (lower half). PtdIns(4,5)P2 and Ptdlns(3,4,5)P3 are shown as PIP2 and PIP3, respectively. RAC-PKot purified from cells without 
treatment and from heat-treated cells are denoted ( - )  and (hs), respectively. The positions of phosphorylated core histone are indicated by ar- 
rows. (B) Quantitation of the results of A. Circles and triangles indicate the enzyme purified from cells with and without heat-treatment, respec- 
tively. Open and closed symbols correspond to the activity in the presence of PtdIns(3,4,5)P3 and PtdIns(4,5)P2, respectively. The -fold stimula- 
tion of the RAC-PKcc activity relative to the enzyme purified enzyme from untreated cells is shown. 
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not show detectable nzyme activity, confirming that the en- 
zyme preparations obtained in these experiments are free from 
other protein kinases (data not shown). It has been reported 
that RAC-PK  activated by serum in Swiss 3T3 cells is phos- 
phorylated on serine and threonine residues and shows de- 
creased mobility on SDS-PAGE, and phosphatase treatment 
of the immunoprecipitated RAC-PK from stimulated cells 
changes electrophoretic mobility and results in the reduction 
of kinase activity to the basal level [19]. RAC-PK purified 
from heat-treated and control cells cultured in the presence 
of serum showed the same mobility on SDS-PAGE as judged 
by protein staining and immunoblot analysis (Fig. 2A). It is 
not clear why the active enzyme obtained from heat-shocked 
cells in this study does not show a different mobility from the 
inactive enzyme. It might be possible that serum enhances the 
phosphorylation of RAC-PK whereas heat shock activates the 
enzyme without phosphorylation of RAC-PK.  
RAC-PK  has been indicated to be a downstream target of 
PI 3-kinase, and PtdIns(3)P, a product of the PI 3-kinase 
reaction, has been shown to activate the enzyme, presumably 
by associating with the PH domain of RAC-PK [15]. On the 
other hand, it has been reported that RAC-PK binds to 
PtdIns(3,4,5)P3 and Ptdlns(3,4)P2, however, PtdIns(3)P is in- 
ert for the binding, and furthermore, the interaction of RAC- 
PK with PtdIns(3,4,5)P3 and PtdIns(3,4)P2 does not activate 
the kinase activity [23]. Thus, the effect of PtdIns(3,4,5)P3 was 
studied using RAC-PK  purified from transfected COS-7 cells 
(Fig. 3). PtdIns(3,4,5)P3 did not activate the enzyme isolated 
from control cells. RAC-PK,  activated approx. 9-fold by heat 
shock through a pathway independent of PI 3-kinase, was not 
enhanced by PtdIns(3,4,5)P3, either, and rather inhibited by 
Ptdlns(4,5)P2 at higher concentrations. PtdIns(4,5)P2 had no 
effect on the enzyme activity isolated from control cells. These 
results indicate that RAC-PK  is not activated by the simple 
association with PtdIns(3,4,5)P3, however, PtdIns(4,5)P2 
could associate with the PH domain of RAC-PK.  It is still 
not known how RAC-PK  is activated by stress. Further stud- 
ies are necessary to elucidate the molecular mechanisms of 
activation of RAC-PK through different signaling pathways. 
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